Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | CASP1 | P29466 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.30 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13408727 | 0.90 | ALDH1A1 (0.31) | ALDH1A1HPGDTSHRMAPK1CASP1 | |
| SCHEMBL13408742 | 0.90 | GSTP1 (0.30) | — | |
| SCHEMBL13408875 | 0.89 | MCL1 (0.36) | ALDH1A1HPGDTSHRMAPK1CASP1 | |
| SCHEMBL13408823 | 0.87 | HPGD (0.34) | ALDH1A1HPGDMAPK1 | |
| SCHEMBL13408699 | 0.87 | — | — | |
| SCHEMBL13408873 | 0.86 | GPR84 (0.38) | ALDH1A1HPGDTSHRMAPK1CASP1 | |
| SCHEMBL13445033 | 0.79 | — | — | |
| SCHEMBL13445044 | 0.74 | — | — | |
| SCHEMBL13706285 | 0.74 | CYP11B1 (0.41) | ALDH1A1HPGDTSHRMAPK1CASP1 | |
| SCHEMBL13706166 | 0.73 | CYP11B1 (0.36) | ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100096982-A1 | Novel organic electroluminescent compounds and organic electrouminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-04-22 | — | — | US | disclosed |
| US-20100096982-A1 | Novel organic electroluminescent compounds and organic electrouminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-04-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100096982-A1 | Novel organic electroluminescent compounds and organic electrouminescent device using the same | OCIAD1, OR10J3, ORMDL3 | ALDH1A1 208/4885HPGD 785/4885TSHR 3168/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.